Patents by Inventor Jing-ping Li

Jing-ping Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11979912
    Abstract: Methods, systems, and devices for wireless communications are described. A user equipment (UE) may use easily detectable transmission parameters to infer difficult-to-detect parameters for communications with a base station. For example, the base station may provide the UE with multiple sets of transmission parameters, and the UE 115 may choose from among these sets of transmission parameters for the communications. In some cases, the UE may be configured with a reference set of transmission parameters, receive one or more transmission parameters that are different relative to the reference set of transmission parameters, and then determine to use the different transmission parameters for the communications. Additionally or alternatively, the multiple sets of transmission parameters may be specified for a certain uplink message (e.g., random access channel messages), where the UE selects the transmission parameter set based on one or more characteristics of the uplink message.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: May 7, 2024
    Assignee: QUALCOMM Incorporated
    Inventors: Gabi Sarkis, Jing Lei, Alexandros Manolakos, Alberto Rico Alvarino, Chih-Ping Li, Seyedkianoush Hosseini
  • Patent number: 11956788
    Abstract: Methods, systems, and devices for wireless communications are described. A transmitting device may transmit an expiration indication to a receiving device as part of a scheduling message for a transport block. The expiration indication may provide information related to an expiration time for the transport block. If the expiration time is reached prior to successful reception by a receiving device, the receiving device may assume that the transport block has expired and may refrain from transmitting a retransmission grant, or may empty a hybrid automatic repeat request (HARM) buffer associated with the transport block. If the transmitting device fails to successfully receive an indication from the receiving device of a successful reception of the transport block prior to the expiration period, the transmitting device may also assume that the transport block has expired.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: April 9, 2024
    Assignee: QUALCOMM Incorporated
    Inventors: Wei Yang, Jing Jiang, Wanshi Chen, Peter Gaal, Tingfang Ji, Chih-Ping Li, Seyedkianoush Hosseini
  • Patent number: 11950273
    Abstract: Methods, systems, and devices for wireless communication are described. In one example, a base station may dynamically configure a user equipment (UE) to monitor or avoid monitoring for a preemption indication. Accordingly, the UE may have a lower chance of monitoring for a preemption indication when it is unlikely that an uplink or downlink transmission will be preempted. In another example, a base station may transmit a control message indicating whether future indications received from the base station are to be interpreted as preemption indications or permission indications. Accordingly, the base station may choose to use either preemption indications or permission indications (e.g., based on the probability of collisions between mobile broadband (MBB) and low latency transmissions) to facilitate MBB and low latency communication multiplexing with limited signaling.
    Type: Grant
    Filed: February 27, 2023
    Date of Patent: April 2, 2024
    Assignee: QUALCOMM Incorporated
    Inventors: Wei Yang, Jing Jiang, Chih-Ping Li, Seyedkianoush Hosseini, Heechoon Lee
  • Publication number: 20040191867
    Abstract: An isolated or recombinant DNA sequence coding for a mammalian, including human, glucuronyl C5-epimarase or a functional derivative thereof capable of converting D-glucuronic acid (GlcA) to L-iduronic acid (IdoA); a recombinant expression vector comprising such DNA sequence; a host cell transformed with such recombinant expression vector; a process for the manufacture of a glucuronyl C5-epimerase or functional derivative thereof capable of converting GlcA to IdoA, comprising cultivation of a cell-line transformed with such recombinant expression vector; and a glucuronyl C5-epimerase or functional derivative thereof prepared by such process.
    Type: Application
    Filed: April 30, 2004
    Publication date: September 30, 2004
    Inventors: Ulf Lindahl, Jing-ping Li
  • Patent number: 6764844
    Abstract: An isolated or recombinant DNA sequence coding for a mammalian, including human, glucuronyl C5-epimerase or a functional derivative thereof capable or converting D-glucuronyl acid (GlcA) to L-iduronic acid (IdoA); a recombinant expression vector comprising such DNA sequence; a host cell transformed with such recombinant expression vector; a process for manufacture of a glucuronyl C5-epimerase or functional derivative thereof capable of coverting GlcA to IdoA, comprising cultivation of a cell-line transformed with such recombinant expression vector; and a glucuronyl C5-epimerase or functional derivative thereof prepared by such process.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: July 20, 2004
    Assignee: Biotie Therapies, Corp.
    Inventors: Ulf Lindahl, Jing-ping Li